Literature DB >> 28205604

Selectively Bred Rats Provide a Unique Model of Vulnerability to PTSD-Like Behavior and Respond Differentially to FGF2 Augmentation Early in Life.

Katherine E Prater1,2, Elyse L Aurbach1,2, Hanna K Larcinese1, Taylor N Smith1, Cortney A Turner1, Peter Blandino1, Stanley J Watson1, Stephen Maren3, Huda Akil1.   

Abstract

Individuals respond differently to traumatic experiences, including their propensity to develop posttraumatic stress disorder (PTSD). Understanding individual differences in PTSD vulnerability will allow the development of improved prevention and treatment options. Here we characterized fear conditioning and extinction in rats selectively bred for differences in their locomotor response to a novel environment. Selectively bred high-responder (bHR) and low-responder (bLR) male rats are known to differ in their emotional reactivity on a range of measures of spontaneous anxiety- and depressive-like behaviors. We demonstrate that bHRs have facilitated extinction learning and retention compared with outbred Sprague Dawley rats, whereas bLRs show reduced extinction learning and retention. This indicates that bLRs are more vulnerable to PTSD-like behavior. Fibroblast growth factor 2 (FGF2) has previously been implicated in the development of these behavioral phenotypes and facilitates extinction learning in outbred animals, therefore we examined the effects of early-life FGF2 on bHR and bLR behavior. FGF2 administered on the day after birth facilitated extinction learning and retention in bHRs, but not in bLRs or control rats, during adulthood. This indicates that, under the current fear conditioning paradigm, early-life FGF2 has protective effects only in resilient animals. This stands in contrast to FGF2's ability to protect vulnerable animals in milder tests of anxiety. These results provide a unique animal model of individual differences in PTSD-like behavior, allowing the study of genetic, developmental, and environmental factors in its expression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28205604      PMCID: PMC5518903          DOI: 10.1038/npp.2017.37

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  31 in total

1.  Fibroblast growth factor 9 is a novel modulator of negative affect.

Authors:  Elyse L Aurbach; Edny Gula Inui; Cortney A Turner; Megan H Hagenauer; Katherine E Prater; Jun Z Li; Devin Absher; Najmul Shah; Peter Blandino; William E Bunney; Richard M Myers; Jack D Barchas; Alan F Schatzberg; Stanley J Watson; Huda Akil
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

Review 2.  Memory of fearful events: the role of fibroblast growth factor-2 in fear acquisition and extinction.

Authors:  B M Graham; R Richardson
Journal:  Neuroscience       Date:  2011-05-27       Impact factor: 3.590

3.  De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder.

Authors:  S P Orr; L J Metzger; N B Lasko; M L Macklin; T Peri; R K Pitman
Journal:  J Abnorm Psychol       Date:  2000-05

4.  Fibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fear.

Authors:  Bronwyn M Graham; Rick Richardson
Journal:  Neuropsychopharmacology       Date:  2010-02-03       Impact factor: 7.853

5.  D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.

Authors:  JoAnn Difede; Judith Cukor; Katarzyna Wyka; Megan Olden; Hunter Hoffman; Francis S Lee; Margaret Altemus
Journal:  Neuropsychopharmacology       Date:  2013-11-12       Impact factor: 7.853

6.  Antidepressant-like effects of intracerebroventricular FGF2 in rats.

Authors:  Cortney A Turner; Edny L Gula; Larry P Taylor; Stanley J Watson; Huda Akil
Journal:  Brain Res       Date:  2008-06-14       Impact factor: 3.252

7.  Latent profiles of DSM-5 PTSD symptoms and the "Big Five" personality traits.

Authors:  Ateka A Contractor; Cherie Armour; M Tracie Shea; Natalie Mota; Robert H Pietrzak
Journal:  J Anxiety Disord       Date:  2015-10-20

Review 8.  Neuroscience of fear extinction: implications for assessment and treatment of fear-based and anxiety related disorders.

Authors:  Mohammed R Milad; Blake L Rosenbaum; Naomi M Simon
Journal:  Behav Res Ther       Date:  2014-08-23

9.  Predicting post-trauma stress symptoms from pre-trauma psychophysiologic reactivity, personality traits and measures of psychopathology.

Authors:  Scott P Orr; Natasha B Lasko; Michael L Macklin; Suzanne L Pineles; Yuchiao Chang; Roger K Pitman
Journal:  Biol Mood Anxiety Disord       Date:  2012-05-18

10.  Individual differences in the expression of conditioned fear are associated with endogenous fibroblast growth factor 2.

Authors:  Bronwyn M Graham; Rick Richardson
Journal:  Learn Mem       Date:  2015-12-15       Impact factor: 2.460

View more
  10 in total

1.  Effects of early-life FGF2 on ultrasonic vocalizations (USVs) and the mu-opioid receptor in male Sprague-Dawley rats selectively-bred for differences in their response to novelty.

Authors:  Cortney A Turner; Megan H Hagenauer; Elyse L Aurbach; Pamela M Maras; Chelsea L Fournier; Peter Blandino; Rikav B Chauhan; Jaak Panksepp; Stanley J Watson; Huda Akil
Journal:  Brain Res       Date:  2019-03-14       Impact factor: 3.252

Review 2.  Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.

Authors:  Michael A Emery; Huda Akil
Journal:  Annu Rev Neurosci       Date:  2020-02-28       Impact factor: 12.449

Review 3.  Revisiting the Stress Concept: Implications for Affective Disorders.

Authors:  Bruce S McEwen; Huda Akil
Journal:  J Neurosci       Date:  2020-01-02       Impact factor: 6.167

4.  Individual Differences Make a Marker in Fear Research.

Authors:  Katherine E Prater
Journal:  Biol Psychiatry       Date:  2017-10-15       Impact factor: 13.382

5.  The Association Between Salivary FGF2 and Physiological and Psychological Components of the Human Stress Response.

Authors:  Emma M Bryant; Rick Richardson; Bronwyn M Graham
Journal:  Chronic Stress (Thousand Oaks)       Date:  2022-07-18

Review 6.  Sex-Specific Brain Transcriptional Signatures in Human MDD and Their Correlates in Mouse Models of Depression.

Authors:  Maureen Touchant; Benoit Labonté
Journal:  Front Behav Neurosci       Date:  2022-05-03       Impact factor: 3.617

7.  Inhibition of FGF Receptor-1 Suppresses Alcohol Consumption: Role of PI3 Kinase Signaling in Dorsomedial Striatum.

Authors:  Oren Even-Chen; Segev Barak
Journal:  J Neurosci       Date:  2019-08-02       Impact factor: 6.167

8.  Genetic Liability for Internalizing Versus Externalizing Behavior Manifests in the Developing and Adult Hippocampus: Insight From a Meta-analysis of Transcriptional Profiling Studies in a Selectively Bred Rat Model.

Authors:  Isabelle A Birt; Megan H Hagenauer; Sarah M Clinton; Cigdem Aydin; Peter Blandino; John D H Stead; Kathryn L Hilde; Fan Meng; Robert C Thompson; Huzefa Khalil; Alex Stefanov; Pamela Maras; Zhifeng Zhou; Elaine K Hebda-Bauer; David Goldman; Stanley J Watson; Huda Akil
Journal:  Biol Psychiatry       Date:  2020-05-27       Impact factor: 13.382

9.  Inborn differences in emotional behavior coincide with alterations in hypothalamic paraventricular motor projections.

Authors:  Elizabeth A Shupe; Matthew E Glover; Keaton A Unroe; Ilan A Kerman; Sarah M Clinton
Journal:  Eur J Neurosci       Date:  2020-12-15       Impact factor: 3.386

Review 10.  Modeling heritability of temperamental differences, stress reactivity, and risk for anxiety and depression: Relevance to research domain criteria (RDoC).

Authors:  Sarah M Clinton; Elizabeth A Shupe; Matthew E Glover; Keaton A Unroe; Chelsea R McCoy; Joshua L Cohen; Ilan A Kerman
Journal:  Eur J Neurosci       Date:  2021-03-24       Impact factor: 3.698

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.